文献速递细菌感染、耐药与抗菌药物医院感染防控

控制干预措施对英格兰艰难梭菌感染的影响:一项观察性研究

Effects of control interventions on Clostridium difficile infection in England: an observational study.
PubMed 文献 · Lancet Infect Dis · 2017-01-25

该研究结合1998-2014年英格兰地区和国家艰难梭菌感染发生率、抗菌药物处方数据及4045株全基因组序列,检验氟喹诺酮类耐药与医院感染控制对感染下降的作用。结果显示氟喹诺酮类和头孢菌素处方与感染发生率高度相关,耐药菌株消除驱动了感染下降,提示抗菌药物管理是感染控制的核心。

要点

  • 氟喹诺酮类和头孢菌素处方与艰难梭菌感染发生率高度相关。
  • 牛津郡氟喹诺酮耐药菌株所致感染从约67%降至约3%。
  • 限制氟喹诺酮类处方而非仅加强感染控制解释了感染下降。

核心结论

  • 限制氟喹诺酮类处方似乎解释了英格兰牛津郡和利兹艰难梭菌感染发生率的下降,优于其他措施。
  • 抗菌药物管理应成为艰难梭菌感染控制规划的核心组成部分。

研究设计与样本

  • 观察性研究,结合英格兰牛津郡和利兹的区域数据及国家数据(1998-2014年)与4045株国家和国际艰难梭菌分离株的全基因组序列。
  • 通过全基因组序列确定基因型(多位点序列分型)和氟喹诺酮敏感性,使用负二项回归估计耐药和敏感菌株所致感染发生率,并用系统发育分析研究选择和传播。

主要发现

  • 系统发育中包含氟喹诺酮耐药菌株的区域分支短且具地理结构,符合选择和快速传播。

临床怎么用

  • 在艰难梭菌感染控制规划中,应将抗菌药物管理(尤其是限制氟喹诺酮类处方)作为核心干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The control of Clostridium difficile infections is an international clinical challenge. The incidence of C difficile in England declined by roughly 80% after 2006, following the implementation of national control policies; we tested two hypotheses to investigate their role in this decline. First, if C difficile infection declines in England were driven by reductions in use of particular antibiotics, then incidence of C difficile infections caused by resistant isolates should decline faster than that caused by susceptible isolates across multiple genotypes. Second, if C difficile infection declines were driven by improvements in hospital infection control, then transmitted (secondary) cases should decline regardless of susceptibility. METHODS: Regional (Oxfordshire and Leeds, UK) and national data for the incidence of C difficile infections and antimicrobial prescribing data (1998-2014) were combined with whole genome sequences from 4045 national and international C difficile isolates. Genotype (multilocus sequence type) and fluoroquinolone susceptibility were determined from whole genome sequences. The incidence of C difficile infections caused by fluoroquinolone-resistant and fluoroquinolone-susceptible isolates was estimated with negative-binomial regression, overall and per genotype. Selection and transmission were investigated with phylogenetic analyses. FINDINGS: National fluoroquinolone and cephalosporin prescribing correlated highly with incidence of C difficile infections (cross-correlations >0·88), by contrast with total antibiotic prescribing (cross-correlations <0·59). Regionally, C difficile decline was driven by elimination of fluoroquinolone-resistant isolates (approximately 67% of Oxfordshire infections in September, 2006, falling to approximately 3% in February, 2013; annual incidence rate ratio 0·52, 95% CI 0·48-0·56 vs fluoroquinolone-susceptible isolates: 1·02, 0·97-1·08). C difficile infections caused by fluoroquinolone-resistant isolates declined in four distinct genotypes (p<0·01). The regions of phylogenies containing fluoroquinolone-resistant isolates were short-branched and geographically structured, consistent with selection and rapid transmission. The importance of fluoroquinolone restriction over infection control was shown by significant declines in inferred secondary (transmitted) cases caused by fluoroquinolone-resistant isolates with or without hospital contact (p<0·0001) versus no change in either group of cases caused by fluoroquinolone-susceptible isolates (p>0·2). INTERPRETATION: Restricting fluoroquinolone prescribing appears to explain the decline in incidence of C difficile infections, above other measures, in Oxfordshire and Leeds, England. Antimicrobial stewardship should be a central component of C difficile infection control programmes. FUNDING: UK Clinical Research Collaboration (Medical Research Council, Wellcome Trust, National Institute for Health Research); NIHR Oxford Biomedical Research Centre; NIHR Health Protection Research Unit on Healthcare Associated Infection and Antimicrobial Resistance (Oxford University in partnership with Public Health England [PHE]), and on Modelling Methodology (Imperial College, London in partnership with PHE); and the Health Innovation Challenge Fund.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dingle KE, Didelot X, Quan TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017. PMID: 28130063. doi:10.1016/S1473-3099(16)30514-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。